More News of Interest

Martin J. Madden Joins Novocure Board of Directors


The company said that Mr. Madden recently retired after a 30-year career in medical device innovation at Johnson & Johnson but recently served as Vice President, Research and Development DePuy-Synthes and Vice President Medical Device R&D Transformation

Novocure (NASDAQ:NVCR) today announced that Martin J. Madden, a longtime leader in the medical device industry, was elected to its Boards of Directors during Novocure’s 2017 annual general meeting of shareholders. In addition, Mr. Madden has been appointed to Novocure’s Audit and Nominating and Corporate Governance Committees.

“We’re extremely pleased to welcome Martin to our board,” said Bill Doyle, Novocure’s Executive Chairman. “Martin’s extensive experience as a leader of medical device development and commercialization will be invaluable as we continue to execute our mission to bring a profoundly different cancer treatment to patients.”

The company said that Mr. Madden recently retired after a 30-year career in medical device innovation at Johnson & Johnson but recently served as Vice President, Research and Development DePuy-Synthes and Vice President Medical Device R&D Transformation. In addition, Mr. Madden was a medical device engineer and innovator, and a leader of cross-functional teams charged with incubating, developing, and launching new products.  He holds an MBA from Columbia University, a Master’s degree in Mechanical Engineering from Carnegie-Mellon University and a Bachelor’s degree in Mechanical Engineering from the University of Dayton.

Mr. Madden is also a member of the Board of Directors for Microbot Medical Inc., a medical device company specializing in micro-robotic medical technologies.

Latest Posts

Don't Miss